ALS

Pharma

Amylyx's ALS drug finally scores a positive vote from FDA panel

Yesterday was the long-awaited second meeting of the FDA’s expert panel to weigh in on Amylyx’s ALS drug, and this time, AMX0035 came away with a nod.
Zoey Becker Sep 8, 2022 8:16am

Amylyx's ALS drug faces tough FDA scrutiny—again

Sep 6, 2022 4:38pm

ALS Association pushes for FDA approval of pending Amylyx drug

Sep 15, 2021 11:11am

New Alzheimer's drug gives price reformers their poster child

Jun 10, 2021 10:29am

JPM: Alexion to take next-gen Ultomiris into tough ALS study

Jan 14, 2020 5:00pm

Radicava stalls in EU as skeptical regulators demand new ALS trial

May 31, 2019 12:19pm